PharmChem Performance

PCHMDelisted Stock  USD 3.75  0.01  0.27%   
The company holds a Beta of 0.73, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PharmChem's returns are expected to increase less than the market. However, during the bear market, the loss of holding PharmChem is expected to be smaller as well. PharmChem right now holds a risk of 0.0%. Please check PharmChem potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if PharmChem will be following its historical price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, PharmChem is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
  

PharmChem Relative Risk vs. Return Landscape

If you would invest  375.00  in PharmChem on November 14, 2025 and sell it today you would earn a total of  0.00  from holding PharmChem or generate 0.0% return on investment over 90 days. PharmChem is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than PharmChem, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

PharmChem Target Price Odds to finish over Current Price

The tendency of PharmChem Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.75 90 days 3.75 
about 46.38
Based on a normal probability distribution, the odds of PharmChem to move above the current price in 90 days from now is about 46.38 (This PharmChem probability density function shows the probability of PharmChem Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days PharmChem has a beta of 0.73 indicating as returns on the market go up, PharmChem average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding PharmChem will be expected to be much smaller as well. Additionally PharmChem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   PharmChem Price Density   
       Price  

Predictive Modules for PharmChem

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PharmChem. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.753.753.75
Details
Intrinsic
Valuation
LowRealHigh
3.143.144.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PharmChem. Your research has to be compared to or analyzed against PharmChem's peers to derive any actionable benefits. When done correctly, PharmChem's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PharmChem.

PharmChem Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. PharmChem is not an exception. The market had few large corrections towards the PharmChem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PharmChem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PharmChem within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.03
β
Beta against Dow Jones0.73
σ
Overall volatility
0.11
Ir
Information ratio -0.02

PharmChem Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PharmChem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PharmChem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
PharmChem is not yet fully synchronised with the market data
PharmChem has a very high chance of going through financial distress in the upcoming years
The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity.
PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M.

PharmChem Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PharmChem Pink Sheet often depends not only on the future outlook of the current and potential PharmChem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PharmChem's indicators that are reflective of the short sentiment are summarized in the table below.
Short Long Term Debt1.9 M
Forward Annual Dividend Rate0.12

PharmChem Fundamentals Growth

PharmChem Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of PharmChem, and PharmChem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PharmChem Pink Sheet performance.

About PharmChem Performance

By examining PharmChem's fundamental ratios, stakeholders can obtain critical insights into PharmChem's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that PharmChem is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. Pharmchem is traded on OTC Exchange in the United States.

Things to note about PharmChem performance evaluation

Checking the ongoing alerts about PharmChem for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for PharmChem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PharmChem is not yet fully synchronised with the market data
PharmChem has a very high chance of going through financial distress in the upcoming years
The company has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist PharmChem until it has trouble settling it off, either with new capital or with free cash flow. So, PharmChem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PharmChem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PharmChem to invest in growth at high rates of return. When we think about PharmChem's use of debt, we should always consider it together with cash and equity.
PharmChem reported the previous year's revenue of 26.45 M. Net Loss for the year was (2.15 M) with profit before overhead, payroll, taxes, and interest of 5.86 M.
Evaluating PharmChem's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate PharmChem's pink sheet performance include:
  • Analyzing PharmChem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PharmChem's stock is overvalued or undervalued compared to its peers.
  • Examining PharmChem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating PharmChem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PharmChem's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of PharmChem's pink sheet. These opinions can provide insight into PharmChem's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating PharmChem's pink sheet performance is not an exact science, and many factors can impact PharmChem's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in PharmChem Pink Sheet

If you are still planning to invest in PharmChem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PharmChem's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments